See outcomes before you decide

Revaz analyzes multimodal patient data to generate personalized treatment outcome predictions, supporting evidence-based revascularization decisions.

NVIDIA Inception Program
Alberta Health
University of Ottawa
Amazon Web Services
ottawa hospital
Partner
agewell
Technology Alberta
Plug and Play
echo
elevate ip
NVIDIA Inception Program
Alberta Health
University of Ottawa
Amazon Web Services
ottawa hospital
Partner
agewell
Technology Alberta
Plug and Play
echo
elevate ip

Product Overview

Personalized CAD treatment selection solution

Quantify Individual Risk

Quantify Individual Risk

Understand patient-specific MACE and mortality risk across short- and long-term horizons.

Compare Treatment Strategies

Compare Treatment Strategies

Compare predicted outcomes across PCI, CABG, and medical therapy to support optimal treatment selection.

Explore risk drivers

Explore risk drivers

See how key clinical and anatomical factors contribute to each patient's predicted risk.

Optimize care with insights

David, 77, was diagnosed with triple-vessel CAD with LAD involvement

Doctor pointing at cardiac angiogram with patient
Revaz AI — David Carter's AI Insight Overview

Why Revaz

Designed for every stakeholder in the care pathway

Data-Backed decisions

Built on large-scale real-world datasets to support evidence-based care.

Efficient Heart Team Rounds

Reliable, patient-specific insights to support case presentation and optimal treatment planning in heart teams.

Shared Decision Support

Translate patient specific risks and context to accelerate decisions with patients.

Let the Numbers Speak

0+

Real-world patient cases

$0K USD

Savings per patient

$0K USD

QALY gain per patient

Pricing

A plan for every organization

Revaz AI pricing is tailored to your institution's size, workflow, and clinical needs. Contact us to explore a plan that fits your team.

Contact sales

Evidence

Evidence behind Revaz

Health Economics

With Revaz, we can help you save $23k USD on average per patient, while improving health outcomes and quality of care. Click view study below to read about the healthcare economics benefits of Revaz.

View study

Accuracy and Efficacy

Revaz was developed and maintained by a seasoned, multidisciplinary team; it was tested and proved successful against 44.5k past patients. Click view study below to learn more about Revaz's efficacy and development.

View study

FAQs

Frequently asked questions

Everything you need to know about the product.

Contact Us

Request a demo

Reach out to learn more about Revaz AI or see how Revaz can generate patient insights and add them to your report in just 2 clicks.

Revaz AI, a product of Symbiotic AI. Visit us at symbioticai.ca.

Revaz AI

© 2026 Revaz AI, a product of Symbiotic AI. All rights reserved.